Eversept Partners’s Dynavax Technologies DVAX Stock Holding History

Eversept Partners’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-605,976	Closed	-$9.32M	–	131
2025 Q4	$9.32M	Sell	605,976 -87,551	-13%	-$964K	0.47%	55
2025 Q3	$6.89M	Sell	693,527 -503,662	-42%	-$5.24M	0.47%	45
2025 Q2	$11.9M	Buy	+1,197,189	New	+$12.6M	1.09%	27
2020 Q3	–	Sell	-97,800	Closed	-$867K	–	57
2020 Q2	$867K	Buy	+97,800	New	+$494K	0.12%	62
2018 Q4	–	Sell	-27,000	Closed	-$335K	–	56
2018 Q3	$335K	Hold	27,000	–	–	0.15%	58
2018 Q2	$412K	Sell	27,000 -3,000	-10%	-$51.9K	0.19%	61
2018 Q1	$596K	Buy	+30,000	New	+$518K	0.28%	46

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Eversept Partners's DVAX Position: Q1 2026 in Review

Eversept Partners sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 605,976 shares — an estimated $9.32M sold.

Eversept Partners first reported a position in DVAX in Q1 2018 and held it in 7 quarters. The position peaked at $11.9M in Q2 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Eversept Partners reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Eversept Partners sold 605,976 Dynavax Technologies shares in Q1 2026, an estimated $9.32M.
Eversept Partners first reported a position in Dynavax Technologies in Q1 2018 and held it in 7 quarters.
Eversept Partners's Dynavax Technologies position peaked at $11.9M in Q2 2025.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Eversept Partners's 13F filing for Q1 2026, filed 15 May 2026.